Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma Participants
Clinical trial NCT02004028 · TERMINATED
Trial details
- NCT number
- NCT02004028
- Sponsor
- Verastem, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-12
- Primary completion
- 2019-06-19
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.